There is a study of 196 COVID-19-positive patients that showed that cTnI (≥21 ng/L) is a better prognostic value for 30-day all-cause mortality in comparison with CRP, LDH and D-Dimer [31]. This evidence concerns the gene TNNI3 and COVID-19.